Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Geographic Atrophy Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4944228
  • 102 Pages
  • April 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Geographic Atrophy Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Geographic Atrophy Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Geographic Atrophy Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Geographic Atrophy Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Geographic Atrophy Treatment market, reaching US$ million by the year 2028. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Geographic Atrophy Treatment players cover Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, and Hemera Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Late-stage (Phase III) Treatment

Phase II Treatment

Phase I Treatment

Pre-Clinical Stage Treatment

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Hemera Biosciences

Allegro Ophthalmics

Stealth BioTherapeutics

Gyroscope Therapeutics

Regenerative Patch Technologies

Roche Holding AG

Gensight Biologics SA

NGM Biopharmaceuticals

AstraZeneca

Lineage Cell Therapeutics

Allergan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Geographic Atrophy Treatment Market Size 2017-2028

2.1.2 Geographic Atrophy Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Geographic Atrophy Treatment Segment by Type

2.2.1 Late-stage (Phase III) Treatment

2.2.2 Phase II Treatment

2.2.3 Phase I Treatment

2.2.4 Pre-Clinical Stage Treatment

2.3 Geographic Atrophy Treatment Market Size by Type

2.3.1 Geographic Atrophy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

2.4 Geographic Atrophy Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Geographic Atrophy Treatment Market Size by Application

2.5.1 Geographic Atrophy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

3 Geographic Atrophy Treatment Market Size by Player

3.1 Geographic Atrophy Treatment Market Size Market Share by Players

3.1.1 Global Geographic Atrophy Treatment Revenue by Players (2020-2022)

3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Geographic Atrophy Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Geographic Atrophy Treatment by Regions

4.1 Geographic Atrophy Treatment Market Size by Regions (2017-2022)

4.2 Americas Geographic Atrophy Treatment Market Size Growth (2017-2022)

4.3 APAC Geographic Atrophy Treatment Market Size Growth (2017-2022)

4.4 Europe Geographic Atrophy Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Geographic Atrophy Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Geographic Atrophy Treatment Market Size by Country (2017-2022)

5.2 Americas Geographic Atrophy Treatment Market Size by Type (2017-2022)

5.3 Americas Geographic Atrophy Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Geographic Atrophy Treatment Market Size by Region (2017-2022)

6.2 APAC Geographic Atrophy Treatment Market Size by Type (2017-2022)

6.3 APAC Geographic Atrophy Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Geographic Atrophy Treatment by Country (2017-2022)

7.2 Europe Geographic Atrophy Treatment Market Size by Type (2017-2022)

7.3 Europe Geographic Atrophy Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Geographic Atrophy Treatment by Region (2017-2022)

8.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Geographic Atrophy Treatment Market Forecast

10.1 Global Geographic Atrophy Treatment Forecast by Regions (2023-2028)

10.1.1 Global Geographic Atrophy Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Geographic Atrophy Treatment Forecast

10.1.3 APAC Geographic Atrophy Treatment Forecast

10.1.4 Europe Geographic Atrophy Treatment Forecast

10.1.5 Middle East & Africa Geographic Atrophy Treatment Forecast

10.2 Americas Geographic Atrophy Treatment Forecast by Country (2023-2028)

10.2.1 United States Geographic Atrophy Treatment Market Forecast

10.2.2 Canada Geographic Atrophy Treatment Market Forecast

10.2.3 Mexico Geographic Atrophy Treatment Market Forecast

10.2.4 Brazil Geographic Atrophy Treatment Market Forecast

10.3 APAC Geographic Atrophy Treatment Forecast by Region (2023-2028)

10.3.1 China Geographic Atrophy Treatment Market Forecast

10.3.2 Japan Geographic Atrophy Treatment Market Forecast

10.3.3 Korea Geographic Atrophy Treatment Market Forecast

10.3.4 Southeast Asia Geographic Atrophy Treatment Market Forecast

10.3.5 India Geographic Atrophy Treatment Market Forecast

10.3.6 Australia Geographic Atrophy Treatment Market Forecast

10.4 Europe Geographic Atrophy Treatment Forecast by Country (2023-2028)

10.4.1 Germany Geographic Atrophy Treatment Market Forecast

10.4.2 France Geographic Atrophy Treatment Market Forecast

10.4.3 UK Geographic Atrophy Treatment Market Forecast

10.4.4 Italy Geographic Atrophy Treatment Market Forecast

10.4.5 Russia Geographic Atrophy Treatment Market Forecast

10.5 Middle East & Africa Geographic Atrophy Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Geographic Atrophy Treatment Market Forecast

10.5.2 South Africa Geographic Atrophy Treatment Market Forecast

10.5.3 Israel Geographic Atrophy Treatment Market Forecast

10.5.4 Turkey Geographic Atrophy Treatment Market Forecast

10.5.5 GCC Countries Geographic Atrophy Treatment Market Forecast

10.6 Global Geographic Atrophy Treatment Forecast by Type (2023-2028)

10.7 Global Geographic Atrophy Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Apellis Pharmaceuticals

11.1.1 Apellis Pharmaceuticals Company Information

11.1.2 Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered

11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Apellis Pharmaceuticals Main Business Overview

11.1.5 Apellis Pharmaceuticals Latest Developments

11.2 IVERIC bio

11.2.1 IVERIC bio Company Information

11.2.2 IVERIC bio Geographic Atrophy Treatment Product Offered

11.2.3 IVERIC bio Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 IVERIC bio Main Business Overview

11.2.5 IVERIC bio Latest Developments

11.3 Alkeus Pharmaceuticals

11.3.1 Alkeus Pharmaceuticals Company Information

11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered

11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Alkeus Pharmaceuticals Main Business Overview

11.3.5 Alkeus Pharmaceuticals Latest Developments

11.4 Hemera Biosciences

11.4.1 Hemera Biosciences Company Information

11.4.2 Hemera Biosciences Geographic Atrophy Treatment Product Offered

11.4.3 Hemera Biosciences Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Hemera Biosciences Main Business Overview

11.4.5 Hemera Biosciences Latest Developments

11.5 Allegro Ophthalmics

11.5.1 Allegro Ophthalmics Company Information

11.5.2 Allegro Ophthalmics Geographic Atrophy Treatment Product Offered

11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Allegro Ophthalmics Main Business Overview

11.5.5 Allegro Ophthalmics Latest Developments

11.6 Stealth BioTherapeutics

11.6.1 Stealth BioTherapeutics Company Information

11.6.2 Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered

11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Stealth BioTherapeutics Main Business Overview

11.6.5 Stealth BioTherapeutics Latest Developments

11.7 Gyroscope Therapeutics

11.7.1 Gyroscope Therapeutics Company Information

11.7.2 Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered

11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Gyroscope Therapeutics Main Business Overview

11.7.5 Gyroscope Therapeutics Latest Developments

11.8 Regenerative Patch Technologies

11.8.1 Regenerative Patch Technologies Company Information

11.8.2 Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered

11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Regenerative Patch Technologies Main Business Overview

11.8.5 Regenerative Patch Technologies Latest Developments

11.9 Roche Holding AG

11.9.1 Roche Holding AG Company Information

11.9.2 Roche Holding AG Geographic Atrophy Treatment Product Offered

11.9.3 Roche Holding AG Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Roche Holding AG Main Business Overview

11.9.5 Roche Holding AG Latest Developments

11.10 Gensight Biologics SA

11.10.1 Gensight Biologics SA Company Information

11.10.2 Gensight Biologics SA Geographic Atrophy Treatment Product Offered

11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Gensight Biologics SA Main Business Overview

11.10.5 Gensight Biologics SA Latest Developments

11.11 NGM Biopharmaceuticals

11.11.1 NGM Biopharmaceuticals Company Information

11.11.2 NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered

11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 NGM Biopharmaceuticals Main Business Overview

11.11.5 NGM Biopharmaceuticals Latest Developments

11.12 AstraZeneca

11.12.1 AstraZeneca Company Information

11.12.2 AstraZeneca Geographic Atrophy Treatment Product Offered

11.12.3 AstraZeneca Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AstraZeneca Main Business Overview

11.12.5 AstraZeneca Latest Developments

11.13 Lineage Cell Therapeutics

11.13.1 Lineage Cell Therapeutics Company Information

11.13.2 Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered

11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Lineage Cell Therapeutics Main Business Overview

11.13.5 Lineage Cell Therapeutics Latest Developments

11.14 Allergan

11.14.1 Allergan Company Information

11.14.2 Allergan Geographic Atrophy Treatment Product Offered

11.14.3 Allergan Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Allergan Main Business Overview

11.14.5 Allergan Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Geographic Atrophy Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Late-stage (Phase III) Treatment

Table 3. Major Players of Phase II Treatment

Table 4. Major Players of Phase I Treatment

Table 5. Major Players of Pre-Clinical Stage Treatment

Table 6. Geographic Atrophy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Geographic Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

Table 9. Geographic Atrophy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Geographic Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

Table 12. Global Geographic Atrophy Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Geographic Atrophy Treatment Revenue Market Share by Player (2020-2022)

Table 14. Geographic Atrophy Treatment Key Players Head office and Products Offered

Table 15. Geographic Atrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Geographic Atrophy Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2017-2022)

Table 20. Americas Geographic Atrophy Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Geographic Atrophy Treatment Market Size Market Share by Country (2017-2022)

Table 22. Americas Geographic Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

Table 24. Americas Geographic Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

Table 26. APAC Geographic Atrophy Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Geographic Atrophy Treatment Market Size Market Share by Region (2017-2022)

Table 28. APAC Geographic Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

Table 30. APAC Geographic Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

Table 32. Europe Geographic Atrophy Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Geographic Atrophy Treatment Market Size Market Share by Country (2017-2022)

Table 34. Europe Geographic Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

Table 36. Europe Geographic Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Geographic Atrophy Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Geographic Atrophy Treatment

Table 45. Key Market Challenges & Risks of Geographic Atrophy Treatment

Table 46. Key Industry Trends of Geographic Atrophy Treatment

Table 47. Global Geographic Atrophy Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Geographic Atrophy Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Geographic Atrophy Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 53. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 54. Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered

Table 55. Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Apellis Pharmaceuticals Main Business

Table 57. Apellis Pharmaceuticals Latest Developments

Table 58. IVERIC bio Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 59. IVERIC bio Geographic Atrophy Treatment Product Offered

Table 60. IVERIC bio Main Business

Table 61. IVERIC bio Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. IVERIC bio Latest Developments

Table 63. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 64. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered

Table 65. Alkeus Pharmaceuticals Main Business

Table 66. Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Alkeus Pharmaceuticals Latest Developments

Table 68. Hemera Biosciences Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 69. Hemera Biosciences Geographic Atrophy Treatment Product Offered

Table 70. Hemera Biosciences Main Business

Table 71. Hemera Biosciences Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Hemera Biosciences Latest Developments

Table 73. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 74. Allegro Ophthalmics Geographic Atrophy Treatment Product Offered

Table 75. Allegro Ophthalmics Main Business

Table 76. Allegro Ophthalmics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Allegro Ophthalmics Latest Developments

Table 78. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 79. Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered

Table 80. Stealth BioTherapeutics Main Business

Table 81. Stealth BioTherapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Stealth BioTherapeutics Latest Developments

Table 83. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 84. Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered

Table 85. Gyroscope Therapeutics Main Business

Table 86. Gyroscope Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Gyroscope Therapeutics Latest Developments

Table 88. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 89. Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered

Table 90. Regenerative Patch Technologies Main Business

Table 91. Regenerative Patch Technologies Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Regenerative Patch Technologies Latest Developments

Table 93. Roche Holding AG Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 94. Roche Holding AG Geographic Atrophy Treatment Product Offered

Table 95. Roche Holding AG Main Business

Table 96. Roche Holding AG Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Roche Holding AG Latest Developments

Table 98. Gensight Biologics SA Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 99. Gensight Biologics SA Geographic Atrophy Treatment Product Offered

Table 100. Gensight Biologics SA Main Business

Table 101. Gensight Biologics SA Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Gensight Biologics SA Latest Developments

Table 103. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 104. NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered

Table 105. NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. NGM Biopharmaceuticals Main Business

Table 107. NGM Biopharmaceuticals Latest Developments

Table 108. AstraZeneca Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 109. AstraZeneca Geographic Atrophy Treatment Product Offered

Table 110. AstraZeneca Main Business

Table 111. AstraZeneca Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. AstraZeneca Latest Developments

Table 113. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 114. Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered

Table 115. Lineage Cell Therapeutics Main Business

Table 116. Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Lineage Cell Therapeutics Latest Developments

Table 118. Allergan Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors

Table 119. Allergan Geographic Atrophy Treatment Product Offered

Table 120. Allergan Main Business

Table 121. Allergan Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Allergan Latest Developments

List of Figures

Figure 1. Geographic Atrophy Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Geographic Atrophy Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Geographic Atrophy Treatment Market Size Market Share by Type in 2021

Figure 7. Geographic Atrophy Treatment in Hospital

Figure 8. Global Geographic Atrophy Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Geographic Atrophy Treatment in Clinic

Figure 10. Global Geographic Atrophy Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Global Geographic Atrophy Treatment Market Size Market Share by Application in 2021

Figure 12. Global Geographic Atrophy Treatment Revenue Market Share by Player in 2021

Figure 13. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Geographic Atrophy Treatment Market Size 2017-2022 ($ Millions)

Figure 15. APAC Geographic Atrophy Treatment Market Size 2017-2022 ($ Millions)

Figure 16. Europe Geographic Atrophy Treatment Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Geographic Atrophy Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Americas Geographic Atrophy Treatment Value Market Share by Country in 2021

Figure 19. Americas Geographic Atrophy Treatment Consumption Market Share by Type in 2021

Figure 20. Americas Geographic Atrophy Treatment Market Size Market Share by Application in 2021

Figure 21. United States Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Geographic Atrophy Treatment Market Size Market Share by Region in 2021

Figure 26. APAC Geographic Atrophy Treatment Market Size Market Share by Application in 2021

Figure 27. China Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Geographic Atrophy Treatment Market Size Market Share by Country in 2021

Figure 34. Europe Geographic Atrophy Treatment Market Size Market Share by Type in 2021

Figure 35. Europe Geographic Atrophy Treatment Market Size Market Share by Application in 2021

Figure 36. Germany Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application in 2021

Figure 44. Egypt Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Geographic Atrophy Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 50. APAC Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 51. Europe Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 53. United States Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Canada Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 57. China Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Japan Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 59. Korea Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 61. India Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Australia Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 63. Germany Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 64. France Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 65. UK Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Italy Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 67. Russia Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Spain Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Israel Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Geographic Atrophy Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450